Studies 2 show consuming 1.2-2.0g of protein per kilogram of body weight helps preserve muscle mass during weight loss, which is particularly important on Wegovy as the hunger-lowering effects can lead to insufficient protein intake
Retatrutide is a novel triple receptor agonist (GLP-1, GIP, and glucagon receptor) currently under Phase III clinical investigation for metabolic research applications
Nevertheless, although P5 and Ex4 treatment result in some comparable physiologic responses, our data demonstrate differences in the G-protein-biased agonist mode of action and highlights the divergent roles of GLP-1R-mediated -arrestin signalling in the -cell and adipocyte
While individual experiences vary, the clinical trial data and pharmacological properties of cagrilintide suggest a general timeline
Angelucci, O
Behavior shifts: GLP-1 users across North America report fewer cravings/lower appetite and moderation-related changes in consumption, spending, and restaurant habits